sb 203580 has been researched along with Cardiac Rupture, Traumatic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, C; Guo, J; Qian, F; Qian, Y; Shen, M; Zhang, W; Zhao, L | 1 |
1 other study(ies) available for sb 203580 and Cardiac Rupture, Traumatic
Article | Year |
---|---|
Shengjiang Powder ameliorates myocardial injury in septic rats by downregulating the phosphorylation of P38-MAPK.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Disease Models, Animal; Drugs, Chinese Herbal; Gene Expression Regulation; Heart Injuries; Imidazoles; Interleukin-6; Male; Myocardium; Myocytes, Cardiac; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proliferating Cell Nuclear Antigen; Pyridines; Rats; Rats, Wistar; Sepsis; Signal Transduction; Tumor Necrosis Factor-alpha | 2019 |